Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic coughFirst pivotal ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing ...

They’ve been hailed as miracle drugs, helping millions shed stubborn pounds and cutting the risk of heart attack and stroke by around 20 per cent. But as the use of GLP-1 weight-loss jabs has soared, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with chronic vs. non-chronic cough faced a higher ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Data were derived from Gallagher TJ, et al. JAMA ...

"Oh, that's just from smoking." It's easy to dismiss a chronic cough as another problem with cigarettes. But what if it's a sign of the lung disease COPD? Franziska Gabbert/dpa Long-term smokers often ...

No one wants to be the person who can’t stop coughing. Not only is it uncomfortable on your throat, but it also draws angry stares from others in elevators, subway cars, and restaurants—especially ...

STATE COLLEGE, Pa. (WPVI) -- A cough is supposed to protect the lungs and windpipe from irritants. But coughs that go on and on can be annoying - or signs of bigger problems. Chronic coughs can have ...

Chronic cough is a persistent and often debilitating condition defined as a cough lasting for more than eight weeks. This syndrome presents a significant clinical challenge worldwide due to its ...

A survey of Scripps Health clinicians reveals that specialty and personal risk assessment of side effects drive the chronic ...